Priming with social benefit information of vaccination to increase acceptance of COVID-19 vaccines.

Qiuyan Liao, Benjamin J Cowling, Jingyi Xiao, Jiehu Yuan, Meihong Dong, Michael Y Ni, Richard Fielding, Wendy Wing Tak Lam
Author Information
  1. Qiuyan Liao: School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: qyliao11@hku.hk.
  2. Benjamin J Cowling: School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region; World Health Organization Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region; Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region.
  3. Jingyi Xiao: School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region; World Health Organization Collaborating Center for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region.
  4. Jiehu Yuan: School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
  5. Meihong Dong: School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
  6. Michael Y Ni: School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region; State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong Special Administrative Region; Healthy High Density Cities Lab, HKUrbanLab, The University of Hong Kong, Hong Kong Special Administrative Region.
  7. Richard Fielding: School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.
  8. Wendy Wing Tak Lam: School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.

Abstract

Vaccine hesitancy can be heightened due to increasing negative reports about vaccines. Emphasizing the social benefits of vaccination may shift individual attention from individual to social benefit of vaccination and hence promote prosocial vaccination. In six rounds of a population-based survey conducted over one major community epidemic of coronavirus disease 2019 (COVID-19) in Hong Kong from June to November 2020, we manipulated the question asking about acceptance of a COVID-19 vaccine with or without emphasizing the social benefit of vaccination against COVID-19 (prosocial priming) and monitored the changes of vaccine confidence by news media sentiment on vaccines. Population-weighted percentages of accepting COVID-19 vaccines by priming condition and vaccine confidence were compared across survey rounds. Logit regression models assessed the main effect of prosocial priming and the modification effects of vaccine confidence and perceived personal risk from COVID-19 on acceptance of COVID-19 vaccines. We found that prosocial priming significantly increased acceptance of COVID-19 vaccines across all survey rounds except for Round 3 when incidence of COVID-19 reached a peak. Vaccine confidence significantly declined in Round 6 when news media sentiment on vaccines became predominantly negative. The effect of prosocial priming on promoting vaccine acceptance was significantly greater in participants with low vaccine confidence and those perceiving the severity of COVID-19 to be mild/very mild. Our study suggests that packaging vaccination against COVID-19 as a prosocial behaviour can help overcome low vaccine confidence and promote prosocial vaccination particularly when disease incidence temporarily declines and the public perceive low severity of COVID-19.

Keywords

References

  1. J Psychol. 1975 Sep;91(1):93-114 [PMID: 28136248]
  2. Lancet Public Health. 2020 May;5(5):e279-e288 [PMID: 32311320]
  3. Vaccines (Basel). 2020 Oct 08;8(4): [PMID: 33049956]
  4. Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):14890-14899 [PMID: 32541033]
  5. Vaccine. 2018 Jun 18;36(26):3861-3867 [PMID: 29605516]
  6. PLoS One. 2011 Mar 11;6(3):e17713 [PMID: 21412418]
  7. Nat Hum Behav. 2017 Dec;1(12):873-880 [PMID: 31024188]
  8. Front Neurosci. 2012 Jul 12;6:105 [PMID: 22807893]
  9. Vaccine. 2019 Feb 21;37(9):1168-1173 [PMID: 30709722]
  10. PLoS One. 2013 Aug 23;8(8):e73049 [PMID: 24009729]
  11. Br J Health Psychol. 2022 May;27(2):300-319 [PMID: 34250684]
  12. Vaccine. 2011 Jul 26;29(33):5519-25 [PMID: 21601606]
  13. Proc Biol Sci. 2011 Jan 7;278(1702):42-9 [PMID: 20667876]
  14. Eur J Epidemiol. 2020 Apr;35(4):325-330 [PMID: 32318915]
  15. PLoS Curr. 2010 Oct 19;2:RRN1188 [PMID: 20972476]
  16. Vaccine. 2011 Sep 2;29(38):6472-84 [PMID: 21756960]
  17. BMJ. 2019 Jul 3;366:l4457 [PMID: 31270071]
  18. Health Commun. 2020 Dec;35(14):1718-1722 [PMID: 33124475]
  19. J Health Soc Behav. 1977 Dec;18(4):348-66 [PMID: 617639]
  20. Nat Hum Behav. 2021 Mar;5(3):337-348 [PMID: 33547453]
  21. Soc Sci Med. 2021 Mar;272:113688 [PMID: 33485215]
  22. Pers Individ Dif. 2021 Feb 15;170:110420 [PMID: 33082614]
  23. Nat Med. 2021 Feb;27(2):225-228 [PMID: 33082575]
  24. Vaccine. 2019 Jul 9;37(30):4124-4132 [PMID: 31186189]
  25. Vaccine. 2015 Aug 14;33(34):4180-90 [PMID: 25896377]
  26. Health Psychol. 2013 Sep;32(9):978-85 [PMID: 24001248]
  27. Vaccine. 2015 Aug 14;33(34):4161-4 [PMID: 25896383]
  28. Health Psychol. 2018 Nov;37(11):1045-1054 [PMID: 30221969]
  29. Vaccine. 2020 Oct 27;38(46):7299-7307 [PMID: 32988690]
  30. Risk Anal. 2015 Jul;35(7):1268-80 [PMID: 25808562]
  31. EBioMedicine. 2016 Oct;12:295-301 [PMID: 27658738]
  32. Hum Vaccin Immunother. 2020 Nov 1;16(11):2586-2593 [PMID: 32693678]
  33. Patient Prefer Adherence. 2018 Sep 06;12:1717-1728 [PMID: 30233151]
  34. Health Psychol. 2018 Apr;37(4):307-315 [PMID: 29389158]
  35. Eur J Epidemiol. 2020 Aug;35(8):785-788 [PMID: 32808095]
  36. Tob Control. 2020 May;29(3):277-281 [PMID: 31005892]
  37. Sci Transl Med. 2010 Dec 8;2(61):61mr1 [PMID: 21148125]
  38. Hum Vaccin Immunother. 2020 May 3;16(5):1055-1061 [PMID: 32017659]
  39. J Pain. 2011 Feb;12(2):236-45 [PMID: 20875775]
  40. Int J Nurs Stud. 2019 Nov;99:103359 [PMID: 31493757]
  41. Pediatrics. 2012 Sep;130(3):522-30 [PMID: 22926181]

MeSH Term

COVID-19
COVID-19 Vaccines
Humans
SARS-CoV-2
Surveys and Questionnaires
Vaccination

Chemicals

COVID-19 Vaccines

Word Cloud

Created with Highcharts 10.0.0COVID-19vaccinesvaccinationprosocialvaccineconfidenceacceptanceprimingVaccinesocialbenefitroundssurveysignificantlylowhesitancycannegativeindividualpromotediseasenewsmediasentimentacrosseffectRoundincidenceseverityPrimingheighteneddueincreasingreportsEmphasizingbenefitsmayshiftattentionhencesixpopulation-basedconductedonemajorcommunityepidemiccoronavirus2019HongKongJuneNovember2020manipulatedquestionaskingwithoutemphasizingmonitoredchangesPopulation-weightedpercentagesacceptingconditioncomparedLogitregressionmodelsassessedmainmodificationeffectsperceivedpersonalriskfoundincreasedexcept3reachedpeakdeclined6becamepredominantlypromotinggreaterparticipantsperceivingmild/verymildstudysuggestspackagingbehaviourhelpovercomeparticularlytemporarilydeclinespublicperceiveinformationincreasedecision-making

Similar Articles

Cited By (11)